Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2011 Jul;469(7):1995-2002.
doi: 10.1007/s11999-011-1789-y. Epub 2011 Feb 1.

Does tranexamic acid save blood in minimally invasive total knee arthroplasty?

Affiliations
Clinical Trial

Does tranexamic acid save blood in minimally invasive total knee arthroplasty?

Po-Chun Lin et al. Clin Orthop Relat Res. 2011 Jul.

Abstract

Background: Tranexamic acid (TEA) reportedly reduces perioperative blood loss in TKA. However, whether it does so in minimally invasive TKA is not clear.

Questions/purposes: We asked whether TEA would reduce blood loss and blood transfusion requirements after minimally invasive TKA.

Patients and methods: We prospectively enrolled 100 patients who underwent minimally invasive TKAs: 50 received one intravenous injection of TEA before deflation of the tourniquet and a control group of 50 patients received an equivalent volume of placebo. We compared changes in hemoglobin, postoperative drainage, total blood loss, and transfusion rates between the two groups.

Results: The total blood loss was less for patients in the TEA group than for the control group: 833 mL (374-1014 mL) versus 1453 mL (733-2537 mL), respectively. The rate of blood transfusion also was less for patients in the TEA group than in the control group (4% versus 20%). The hemoglobin levels on the second and fourth postoperative days were greater for patients in the TEA group than in the control group.

Conclusions: Our data suggest one intraoperative injection of TEA decreased the total blood loss and need for transfusion after minimally invasive TKA.

Level of evidence: Level II, therapeutic study. See the Guidelines for Authors for a complete description of levels of evidence.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
A flow diagram of the patients through the trial phases is shown.

References

    1. Aderinto J, Brenkel IJ. Pre-operative predictors of the requirement for blood transfusion following total hip replacement. J Bone Joint Surg Br. 2004;86:970–973. doi: 10.1302/0301-620X.86B7.14682. - DOI - PubMed
    1. Arnljots B, Wieslander JB, Dougan P, Salemark L. Importance of fibrinolysis in limiting thrombus formation following severe microarterial trauma: an experimental study in the rabbit. Microsurgery. 1991;12:332–339. doi: 10.1002/micr.1920120504. - DOI - PubMed
    1. Astedt B, Liedholm P, Wingerup L. The effect of tranexamic acid on the fibrinolytic activity of vein walls. Ann Chir Gynaecol. 1978;67:203–205. - PubMed
    1. Benoni G, Carlsson A, Petersson C, Fredin H. Does tranexamic acid reduce blood loss in knee arthroplasty? Am J Knee Surg. 1995;8:88–92. - PubMed
    1. Benoni G, Fredin H. Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients. J Bone Joint Surg Br. 1996;78:434–440. - PubMed

Publication types